0001209191-19-024175.txt : 20190409 0001209191-19-024175.hdr.sgml : 20190409 20190409185906 ACCESSION NUMBER: 0001209191-19-024175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190405 FILED AS OF DATE: 20190409 DATE AS OF CHANGE: 20190409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Soteropoulos Paula CENTRAL INDEX KEY: 0001692444 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 19740371 MAIL ADDRESS: STREET 1: 49 WINONA STREET CITY: PEABODY STATE: MA ZIP: 01960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-207-0202 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-05 0 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001692444 Soteropoulos Paula C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210 1 1 0 0 Chief Executive Officer Common Stock 2019-04-05 4 M 0 30000 6.48 A 30000 D Common Stock 2019-04-05 4 S 0 30000 32.11 D 0 D Common Stock 2019-04-08 4 M 0 1787 6.48 A 1787 D Common Stock 2019-04-08 4 S 0 1787 32.1658 D 0 D Stock Option (right to buy) 6.48 2019-04-05 4 M 0 30000 0.00 D 2025-12-15 Common Stock 30000 1712866 D Stock Option (right to buy) 6.48 2019-04-08 4 M 0 1787 0.00 D 2025-12-15 Common Stock 1787 1711079 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The weighted average sale price for the transaction reported was $32.1658, and the range of prices were between $32.11 and $32.20. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The shares vest as follows: 1/4th of the shares vest one year after January 1, 2015;1/48th of the shares vest monthly thereafter over the next three years. /s/ Paula Soteropoulos 2019-04-09